Alexion Pharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Alexion Pharmaceuticals patents 113 in total

Status Patent
Grant
Utility: Method of producing alkaline phosphatase External link
Filling date: 8 Sep 2025 Issue date: 27 Apr 2021
Application
Utility: LIQUID FORMULATIONS OF ANTI-CD200 ANTIBODIES External link
Filling date: 8 Sep 2025 Issue date: 25 Mar 2021
Grant
Utility: Preparation of factor Xa derivatives External link
Filling date: 8 Sep 2025 Issue date: 23 Mar 2021
Grant
Utility: Antidotes for factor Xa inhibitors and methods of using the same External link
Filling date: 8 Sep 2025 Issue date: 23 Mar 2021
Application
Utility: METHODS OF SHIFTING AN ISOELECTRIC PROFILE OF A PROTEIN PRODUCT AND USES THEREOF External link
Filling date: 8 Sep 2025 Issue date: 4 Mar 2021
Grant
Utility: Compositions comprising an anti-C5 antibody External link
Filling date: 8 Sep 2025 Issue date: 23 Feb 2021
Application
Utility: HIGH THROUGHPUT METHOD FOR MEASURING THE PROTEASE ACTIVITY OF COMPLEMENT C3 CONVERTASE External link
Filling date: 8 Sep 2025 Issue date: 28 Jan 2021
Grant
Utility: Methods for treating hypophosphatasia in adolescents and adults External link
Filling date: 8 Sep 2025 Issue date: 26 Jan 2021
Application
Utility: POLYPEPTIDES THAT BIND COMPLEMENT COMPONENT C5 OR SERUM ALBUMIN AND FUSION PROTEINS THEREOF External link
Filling date: 8 Sep 2025 Issue date: 24 Dec 2020
Application
Utility: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT External link
Filling date: 8 Sep 2025 Issue date: 17 Dec 2020
Grant
Utility: Lysosomal storage disease enzymes External link
Filling date: 8 Sep 2025 Issue date: 8 Dec 2020
Application
Utility: HIGH CONCENTRATION ANTI-C5 ANTIBODY FORMULATIONS External link
Filling date: 8 Sep 2025 Issue date: 26 Nov 2020
Grant
Utility: Compositions and methods for treating craniosynostosis External link
Filling date: 8 Sep 2025 Issue date: 3 Nov 2020
Application
Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF GENERALIZED MYASTHENIA GRAVIS External link
Filling date: 8 Sep 2025 Issue date: 22 Oct 2020
Application
Utility: METHODS OF TREATING MYOINTIMAL PROLIFERATION External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: METHODS FOR TREATING HYPOPHOSPHATASIA IN CHILDREN AND ADOLESCENTS External link
Filling date: 8 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PATIENTS WITH MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: METHODS OF IMPROVING CARDIOVASCULAR FUNCTION AND TREATING CARDIOVASCULAR DISEASE USING A RECOMBINANT ECTONUCLEOTIDE PYROPHOSPHATASE PHOSPHODIESTERASE (NPP1) External link
Filling date: 8 Sep 2025 Issue date: 20 Aug 2020
Application
Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) AND ATYPICAL HEMOLYTIC UREMIC SYNDROME (AHUS) External link
Filling date: 8 Sep 2025 Issue date: 13 Aug 2020
Application
Utility: BIOMARKER SIGNATURE FOR PREDICTING TUMOR RESPONSE TO ANTI-CD200 THERAPY External link
Filling date: 8 Sep 2025 Issue date: 23 Jul 2020
Application
Utility: METAL IMPACT ON MANUFACTURING OF ALKALINE PHOSPHATASES External link
Filling date: 8 Sep 2025 Issue date: 16 Jul 2020
Grant
Utility: Methods of shifting an isoelectric profile of a protein product and uses thereof External link
Filling date: 8 Sep 2025 Issue date: 14 Jul 2020
Grant
Utility: Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement External link
Filling date: 8 Sep 2025 Issue date: 7 Jul 2020
Application
Utility: ANTI-C5A ANTIBODIES External link
Filling date: 8 Sep 2025 Issue date: 2 Jul 2020
Application
Utility: TREATMENT OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PATIENTS BY AN INHIBITOR OF COMPLEMENT External link
Filling date: 8 Sep 2025 Issue date: 25 Jun 2020
Application
Utility: METHODS OF TREATING A SUBJECT WITH AN ALKALINE PHOSPHATASE DEFICIENCY External link
Filling date: 8 Sep 2025 Issue date: 11 Jun 2020
Application
Utility: METHODS OF REPLICATING A LARGE SCALE ECULIZUMAB PRODUCTION CELL CULTURE External link
Filling date: 8 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF PROTEIN-LOSING ENTEROPATHY IN PATIENTS External link
Filling date: 8 Sep 2025 Issue date: 4 Jun 2020
Application
Utility: ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS External link
Filling date: 8 Sep 2025 Issue date: 21 May 2020
Application
Utility: METHODS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 7 May 2020
Grant
Utility: N-acetyl-alpha-D-glucosaminidase deficiency compositions and methods External link
Filling date: 8 Sep 2025 Issue date: 28 Apr 2020
Application
Utility: EFFICACY OF AN ANTI-C5 ANTIBODY IN THE PREVENTION OF ANTIBODY MEDIATED REJECTION IN SENSITIZED RECIPIENTS OF A KIDNEY TRANSPLANT External link
Filling date: 8 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: METHODS FOR IDENTIFYING THE HEALTH STATE OF HYPOPHOSPHATASIA (HPP) PATIENTS External link
Filling date: 8 Sep 2025 Issue date: 23 Apr 2020
Application
Utility: COMPOSITIONS COMPRISING AN ANTI-C5 ANTIBODY External link
Filling date: 8 Sep 2025 Issue date: 2 Apr 2020
Application
Utility: METHODS FOR TREATING HYPOPHOSPHATASIA (HPP) IN ADULTS AND ADOLESCENTS External link
Filling date: 8 Sep 2025 Issue date: 2 Apr 2020
Grant
Utility: Methods of treating a subject with an alkaline phosphatase deficiency External link
Filling date: 8 Sep 2025 Issue date: 31 Mar 2020
Application
Utility: TREATING SEIZURE WITH RECOMBINANT ALKALINE PHOSPHATASE External link
Filling date: 8 Sep 2025 Issue date: 26 Mar 2020
Application
Utility: COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEUROMYELITIS OPTICA External link
Filling date: 8 Sep 2025 Issue date: 26 Mar 2020
Grant
Utility: Treatment of paroxysmal nocturnal hemoglobinuria patients by an inhibitor of complement External link
Filling date: 8 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Methods of treating atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria with anti-C5 antibodies External link
Filling date: 8 Sep 2025 Issue date: 10 Mar 2020
Application
Utility: METHODS AND COMPOSITIONS FOR TREATING COMPLEMENT-ASSOCIATED DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 5 Mar 2020
Grant
Utility: Compositions and methods relating to genomic modifications in avian primordial germ cells External link
Filling date: 8 Sep 2025 Issue date: 3 Mar 2020
Application
Utility: LYSOSOMAL STORAGE DISEASE ENZYMES External link
Filling date: 8 Sep 2025 Issue date: 27 Feb 2020
Application
Utility: ASSAY FOR C5B-9 DEPOSITION IN COMPLEMENT-ASSOCIATED DISORDERS External link
Filling date: 8 Sep 2025 Issue date: 20 Feb 2020
Grant
Utility: Recombinant human ADA2 and ADA2 fusion proteins and methods for treating ADA2 deficiencies External link
Filling date: 8 Sep 2025 Issue date: 11 Feb 2020
Application
Utility: METHODS FOR REDUCING LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE External link
Filling date: 8 Sep 2025 Issue date: 6 Feb 2020
Application
Utility: METHOD FOR SIMULTANEOUS QUANTIFICATION OF ALXN1210 AND ECULIZUMAB IN HUMAN SERUM OR URINE External link
Filling date: 8 Sep 2025 Issue date: 30 Jan 2020
Grant
Utility: Methods of replicating a large scale eculizumab production cell culture External link
Filling date: 8 Sep 2025 Issue date: 28 Jan 2020
Application
Utility: COMPOSITIONS AND METHODS FOR INCREASING THE SERUM HALF-LIFE OF A THERAPEUTIC AGENT TARGETING COMPLEMENT C5 External link
Filling date: 8 Sep 2025 Issue date: 23 Jan 2020
Grant
Utility: Methods of treating tissue calcification External link
Filling date: 8 Sep 2025 Issue date: 3 Dec 2019

Showing 50 to 100 of 113 patents.